Comparison Study of the Inflammatory Biomarkers and Cytokine Levels in COVID-19 Patients
Background: ACOVID-19, caused by the novel coronavirus SARS-CoV-2, presents with varying severity, from mild symptoms to severe disease, including ARDS and multi-organ failure. Identifying early biochemical markers to predict the severity of COVID-19 is crucial for improving patient outcomes. Aims a...
Saved in:
| Main Authors: | Dheyaa Saleh Mahdi, Refif Sabih Al-Shawk, Zainab A. Hamid, Suha Maher Abed |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-08-01
|
| Series: | Mustansiriya Medical Journal |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/mj.mj_1_23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Utility of D-dimer and other biomarkers in COVID-19 patients - A prospective study in a tertiary care center
by: Indira Priyadarshini A, et al.
Published: (2022-09-01) -
Association of Inflammatory Markers with the Severity of COVID-19
by: Shubham Mishra, et al.
Published: (2024-07-01) -
Inflammatory biomarkers and adverse outcome in COVID-19: Prelude for future viral pandemics
by: Ankit Kumar, et al.
Published: (2025-02-01) -
BIOMARKERS ROLE IN THE DEVELOPMENT OF SINUS NODE DYSFUNCTION
by: L. M. Vasilets, et al.
Published: (2012-04-01) -
Serum procalcitonin and cerebrospinal fluid cytokines level in children with meningitis
by: A. Denizmen Aygun, et al.
Published: (2004-01-01)